Targeted News Service

Vici Health Sciences Seeks DEA Import Registration for Fentanyl-Related Compounds
August 22, 2025

WASHINGTON, Aug. 22 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration has published a notice regarding an application from Vici Health Sciences LLC, Elkridge, Maryland, for authorization to import fentanyl-related compounds. This controlled substance is a Schedule I drug, and the company plans to use it in a manufacturing process to support its research and clinical trials.

The application, submitted on May 30, 2025, specifies that the company's activity . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form